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The genes encoded by the RD1 locus are known to be important for intracellular 
survival of pathogenic mycobacterium, however their role in counteracting host 
defense is not known.  I hypothesize that RD1 is involved in counteracting host 
oxidative response by secreting ROI-neutralizing enzymes such as catalase and 
superoxide dismutase.    In support of this hypothesis I have shown that M. marinum 
RD1 mutants are more sensitive than wild type to ROIs both in vitro and in BMDM.  
Western blot analysis on the KatG protein levels within the bacterial cells grown in 
7H9 rich medium demonstrated that wild type bacteria produced significantly higher 
amount of KatG than the RD1 mutants.  When the bacteria were exposed for 2 hours 
to H2O2, wild type showed a significant reduction of the KatG level, while the RD1 
mutants maintained constant levels of KatG, suggesting that RD1 genes might be 
involved in the secretion of KatG upon exposure to H2O2.  These results together 
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Chapter 1: Introduction 
It is estimated that one third of the world’s population is infected by Mycobacterium 
tuberculosis.  M. tuberculosis is a facultative intracellular pathogen that survives and 
grows within host macrophages.  An important characteristic of M. tuberculosis infection 
is the formation of granulomas at the site of bacterial implantation. It is the necrotization 
of these granulomas that aids in the aerosol spread of the bacterium.   Of those infected 
with M. tuberculosis, only 10% develop active tuberculosis, the remaining 90% may have 
a low level of infection capable of reactivating at later times (North, 2003).   
One of the characteristics that make M. tuberculosis such a successful pathogen is its 
ability to survive within the toxic environment of the host cell.  After phagocytosis, a 
macrophage will activate numerous defense mechanisms in order to eliminate bacteria as 
well as present antigens to elicit an acquired immune response (Kaufmann, 1988).  M. 
tuberculosis has developed mechanisms to derail the antimicrobicidal processes of the 
host cell and thus persist within the macrophage.  During the process of phagocytosis, 
mycobacterium initiate the transcription of several genes.  This sudden change in gene 
expression likely represents the upregulation of virulence genes necessary for 
overcoming host defenses (Ehrt, 2001).   
One mechanism utilized by mycobacterium to overcome host defense is the inhibition of 
phagolysosome fusion.  Typically a phagosome will undergo a maturation process that 
ends with acidification and fusion to the lysosome.  Mycobacterium block this process by 
inhibiting the preceding increase in cytosolic calcium levels (Malik, 2000).  The 
inhibition of a cytosolic rise in calcium also inhibits another host defense mechanism, 




bacterium and presenting its antigens.  By inhibiting calcium fluxes, mycobacterium 
indirectly inhibits the activation of the caspase cascade that leads to the formation of the 
apoptosome (Briken, 2004). 
The inhibition of phagolysosome fusion and apoptosis ensure mycobacterium survive 
inside the phagosome.  However, to survive within the phagosome, they must overcome 
other aspects of host defense such as reactive oxygen and nitrogen intermediates. 
Reactive Oxygen Intermediates 
Upon phagocytosis, a complex known as NADPH oxidase assembles on the phagosome.  
NADPH oxidase is composed of two membrane-bound components, gp91phox and p22phox, 
and four cytosolic components, p40phox, p47phox, p67phox and RacGTPase.    The position 
of gp91phox and p22phox on the plasma membrane ensures that upon phagosome formation, 
superoxide is generated directly into the phagosome.  This process occurs when p47phox is 
phosphorylated allowing it to transport the complex to the membrane (Heyworth, 1991).  
The NADPH oxidase complex accepts electrons from NADPH and donates them to 
molecular oxygen to generate superoxide (Babior, 1999).  
In 1983, Nathan et al. showed that macrophages activated with gamma interferon 
increased their capacity to release peroxides.  Further research showed that gamma 
interferon activated transcription factors which increased transcription of NADPH 
cytosolic components resulting in a greater number of complexes assembled. In resting 
cells this transcription level is noticeably lower, however, the process of phagocytosis 
alone can activate the assembly of the NADPH complex (Cassatalla, 1990). 
The superoxide generated by NADPH oxidase is the starting material for the formation of 




spontaneous dismutation to form hydrogen peroxide (H2O2).  Hydrogen peroxide can 
then combine with superoxide to form the hydroxyl radical (OH-).  Transition metal 
catalysts enhance this reaction rate via the Haber-Weiss reaction.  Phagocyte-derived 
peroxidases can interact with H2O2 to form HOCl.  Superoxide reduction of HOCl can 
also yield OH- (Miller, 1997). 
The numerous ROIs produced vary in their toxicity.  Superoxide itself is relatively 
unreactive although it may be able to target specific enzymes.  Hydrogen peroxide, OH-, 
and HOCl are much more toxic and can penetrate membranes.  These ROIs are capable 
of extensive damage such as lipid peroxidation; enzyme inactivation and DNA strand 
breaks (Hampton, 1998).   
NADPH oxidase-generated ROIs play an extremely important role in host defense.  
Individuals with chronic granulomatous disease are particularly susceptible to a number 
of infections because they have an inactive NADPH oxidase complex, making them 
unable to generate ROIs which typically kill many intracellular pathogens. Also, mice 
with p47phox-/- show a similar phenotype, characterized by the reduction of the respiratory 
burst and increased susceptibility to infection (Jackson, 1995).   
In addition to the direct effect of ROIs on bacteria within the phagosome, ROIs play a 
significant role in cell signaling within the cytosol.  The ROIs localized to the cytosol has 
two origins, one being from the NADPH oxidase complex and the other from the 
mitochondria (Park, 2004) (Woo, 2004).  Recent evidence has shown that mitochondria 
are induced to produce ROIs in response to bacterial LPS suggesting an important role 
for mitochondrial ROIs in the immune response, most likely through the initiation of 




may be a unique attribute of mitochondrial ROIs (Asehnoune, 2004).  In support of this 
theory, the specific inhibition of mitochondrial ROIs following viral infection leads to 
reduced NFκB activation while the inhibition of NADPH oxidase has no effect 
(Mogensen, 2003).  Thus inhibition of cytosolic ROIs by the ROI inhibitor NAC will 
block NFκB activation, presumably by inhibition of mitochondrial ROIs (Sim, 2005).  
The role of the mitochondria in generating ROIs has been linked to the uncoupling 
protein 2 (UCP2).  This protein is believed to be involved in negatively regulating the 
release of ROI from the mitochondria.  LPS decreases ucp2 expression leading to an 
increase in mitochondrial ROI.  Hence ucp2-/- mice are more resistant to pathogens such 
as Toxoplasma gondii because of an inability to increase mitochondrial ROI levels upon 
infection (Arsenijevic, 2000). The down regulation of ucp2 occurs through Map kinases 
(MapK) and p38 pathways and the subsequent increase in cytosolic ROIs leads to 
increased downstream signaling events such as apoptosis (Emre, 2006).  Consequently, 
bacteria would benefit two fold by eliminating ROIs, decreasing intracellular signaling 
and eliminating the direct toxic effects of ROI on the bacteria. Given the deleterious 
effects of ROIs, it is clear why many pathogens have developed mechanisms to 
counteract them. 
Defense Mechanisms against ROIs  
Some examples of intracellular pathogens that inhibit ROIs include Leishmania 
donovani, Salmonella enterica, Mycobacterium leprae and Brucella abortus.  Leishmania 
promastigotes can express a surface glycoconjugate lipophosphoglycan (LPG), which can 
impair monocyte oxidative responses (Brandonision, 1994).  M. leprae produces a similar 




enterica have multiple mechanisms for inhibiting ROIs including the production of 
antioxidant scavengers, heat shock proteins and superoxide dismutase (Diepen, 2002).  
Another mechanism employed by S. enterica is the inhibition of NADPH oxidase 
recruitment to the phagosome, a mechanism controlled by Salmonella Pathogenicity 
Island 2 (SPI-2).  Research to demonstrate this phenotype showed that in SPI-2 mutants 
NADPH oxidase localized to the phagosome but not in wild type (Vazquez-torres, 2000).   
One ROI-neutralizing mechanism common to many intracellular pathogens is the 
expression of superoxide dismutase (Sod), an enzyme that breaks down superoxide.  E. 
coli that had been genetically altered to allow invasion of epithelial cells were unable to 
survive intracellularly, however their survival increased when they were made to express 
increased levels of periplasmic superoxide dismutase (Battistoni, 2000).  Similarly, 
Salmonella mutants lacking the periplasmic SOD were shown to be much less virulent 
than wild type (de Groote, 1997).  A comparable phenotype is seen in infections with 
Brucella abortus mutants that lack periplasmic SOD (Gee, 2005). 
The mechanisms mentioned above demonstrate the importance of neutralization of ROIs 
for intracellular pathogen survival.  In the case of M. tuberculosis, experimental evidence 
suggests that this intracellular pathogen has developed potent mechanisms for inhibiting 
ROIs (Chan, 1992).  Typically, activated macrophages can inhibit the growth of 
mycobacterium through several mechanisms including the production of ROIs. Yet ROI-
deficient macrophages did not allow any significant growth recovery for M. tuberculosis, 
suggesting that the bacteria are insensitive to ROIs (Chan, 1992).  Research done by 
Chan et al. demonstrated that when macrophages are treated with superoxide dismutase 




M. tuberculosis is insensitive to H2O2 in vitro. This suggests that M. tuberculosis must 
have mechanisms to inhibit or neutralize ROIs.   
Mycobacterial ROI defense mechanisms 
One mechanism by which M. tuberculosis neutralize ROIs is via the enzymes superoxide 
dismutase and catalase.  Superoxide dismutase (Sod) breaks down superoxide to H2O2 
and water; catalase breaks down H2O2 to water and oxygen.  M. tuberculosis has two Sod 
genes, superoxide dismutase A (SodA) which is manganese associated and superoxide 
dismutase C (SodC) which is copper-zinc associated.  Previous studies detail the 
importance of Sod in neutralizing ROIs.  SodC mutants are more sensitive to exogenous 
ROIs and are susceptible to killing by activated wild type bone marrow derived 
macrophages (BMDM) but not by gp91phox-/- BMDM (Piddington, 2001).  SodA is much 
more difficult to study because it appears to be essential for bacteria viability, making a 
SodA null mutant difficult to obtain.  However, studies using mutants with attenuated 
SodA production showed increased sensitivity to H2O2 and attenuated growth in the 
spleen and lungs of mice (Edwards, 2001).   
The M. tuberculosis catalase, KatG, has been well studied since clinical isolates with 
mutations in KatG are resistant to the common antibiotic INH.  These mutants are more 
sensitive to 10 mM H2O2, with killing rates from 43-67% (Manca, 1998).  Also, M. 
tuberculosis ∆katG are more attenuated then wild type in growth in BMDM, but are 
indistinguishable from wild type when infecting gp91phox-/- BMDM (Ng, 2004).  This 
suggests that the KatG mutant’s growth is inhibited by ROIs produced by the 
macrophage.  Further studies on KatG have shown that the integration of katG gene into 




virulence (Wilson, 1995).  This research suggests that KatG plays an important role in 
mycobacterium virulence by contributing to the inhibition of ROIs. 
Taken together, the experimental evidence suggests that both catalase and superoxide 
dismutase are important in counteracting ROIs within macrophages.  While SodC is 
found exclusively intracellularly and on the cell surface, both KatG and SodA have been 
shown to be secreted molecules (Braunstein, 2003).  In addition to other secreted 
molecules, these two enzymes were shown to have activity in culture filtrates of 
pathogenic mycobacterium but not in the culture filtrates of nonpathogenic strains such as 
M. smegmatis (Raynaud, 1998).  This suggests that SodA and KatG may play a role in 
the pathogenesis of M. tuberculosis.  These enzymes are secreted in a SecA2 dependant 
manner.  The deletion of SecA2 led to reduced virulence suggesting that the secretion of 
these two enzymes is an important part of their virulence (Braunstein, 2003). 
Oxidative Stress Response of Mycobacterium 
Many pathogenic bacteria exhibit an inducible oxidative stress response characterized by 
an upregulation of genes involved in protection against oxidative stress.  Since the focus 
of my research involved mycobacterial response to reactive oxygen intermediates, it is 
important to address the issue of gene regulation in response to ROIs.  Mycobacterial 
species possess the gene oxyR, a gene equivalent to the oxidative stress response gene 
found in E. coli (Farr, 1991).  However, Mycobacterium tuberculosis have an inactive 
oxyR gene, caused by several mutations (Deretic, 1995).  In other organism oxyR is 
capable of responding to oxidative stress by inducing transcription of important oxidative 
stress response genes.  In M. tuberculosis, the gene operon believed to be most likely 




regulator of katG and the promoter upstream of furA is required for katG expression 
(Pym, 2001). 
Previous studies have shown that H2O2 can induce the expression of katG directly in an 
oxyR independent manner.  However, there is some debate as to whether this increased 
expression is capable of protecting the bacteria upon further exposure to H2O2 (Sherman. 
1995).  
One interesting aspect of oxidative stress response is the expression of the ahpC gene.  
Alkyl hydroperoxide reductase (AhpC) is a peroxidase encoded by ahpC, a gene located 
down stream of oxyR, which is not interrupted by mutation in M. tuberculosis.  Although 
ahpC expression is generally low in wild type M. tuberculosis, expression increases 
significantly in katG mutant strains suggesting a compensatory role of AhpC (Sherman, 
1996).  Presumably ahpC expression allows the bacterium to maintain a necessary level 
of peroxidase activity in the absence of KatG, which has both catalase and peroxidase 
activity.   
Another interesting characteristic of AhpC is it’s differential induction in virulent versus 
avirulent species of mycobacterium.  In M. bovis BCG, ahpC expression increases upon 
exposure to H2O2.  However, in the pathogenic strains M. bovis and M. tuberculosis, 
expression of ahpC is constitutively lower and no induction occurs (Springer, 2001).  The 
exact role of AhpC in virulence remains unclear.  Studies on ahpC expression during 
infection show that it is silenced in wild type M. tuberculosis and derepressed in BCG.  
This suggests that ahpC expression may not play a role in resistance to host generated 
ROIs or RNIs.  Other experiments have supported this argument showing that ∆ahpC did 




clear whether increased levels of AhpC in avirulent strains corresponds to decreased 
levels of KatG and whether this correlation could explain decreased virulence associated 
with increased ahpC expression.  The increase in ahpC expression in katG negative M. 
tuberculosis isolates would support this claim.  
Reactive Nitrogen Intermediates 
Although the focus of this research is on ROIs, reactive nitrogen intermediates (RNIs) 
and ROIs often work synergistically and both are important mechanisms for 
counteracting bacterial growth.  Activated macrophages upregulate the production of 
nitric oxide (NO), a product of enzymes known as NO synthases.  Similar to the effects 
of ROIs, NO can damage DNA and enzymes.  NO can also combine with superoxide to 
form peroxynitrite, another damaging chemical (Chan, 2001).  Nitric oxide plays an 
important role in inhibiting mycobacterial growth. M. tuberculosis infection of iNOS-/- 
mice shows an increased dissemination of infection (MacMicking,1997).  Despite this 
apparent sensitivity to RNIs, bacteria have developed mechanisms to overcome RNIs in 
the host cell.  For example, the M. tuberculosis noxR1 gene appears to contribute to 
resistance against the toxic effects of RNI although the mechanism is unknown (Ehrt, 
1997). 
RD1 gene loci 
Region of Difference 1 (RD1) is a region of genes that is present in M. tuberculosis but 
absent in the vaccine strain BCG.  RD1 is believed to contribute to the virulence of M. 
tuberculosis and its absence is the reason for attenuation of BCG.  When the vaccine 




RD1 encodes a novel secretion system known as secretion in mycobacterium (snm). Two 
proteins known to be secreted by RD1 are ESAT-6 and CFP-10, both of which lack 
classical secretion signals that would target them to Sec secretion.  Some RD1 genes 
proposed to make up a core part of the secretion system are Rv3870, 3871, 3877.  These 
genes encode a triple ATPase and 12 transmembrane domain.  Deletion of any of these 
genes eliminates ESAT-6 and CFP-10 secretion and results in reduced intracellular 
growth of the mutant (Stanley, 2003). 
Many other RD1 genes have also been shown to be important for secretion of ESAT-6 
and CFP-10 and knocking out any of the essential genes leads to reduced virulence 
(Brodin, 2006).  Similarly, deletion of either esat-6 or cfp-10 results in reduced virulence.  
The precise role these two secreted molecules play is unknown.  M. marinum contains all 
the nine RD1 genes present in M. tuberculosis and experiments on M. marinum have 
shown that several genes outside the RD1 locus, deemed Extended RD1, are also 
required for ESAT-6 secretion (Figure 1) (Gao, 2004). 
In order to further study the role of RD1 in pathogenesis, I will be working with the 
organism Mycobacterium marinum.  There are several advantages in approaching the 
research through M. marinum experiments.  Whereas M. tuberculosis requires stringent 
bsl-3 conditions and has a replication time of 24 hours, M. marinum can be handled in 
bsl-2 conditions and replicates at the much faster rate of six to eight hours.  This 
difference between the two strains will allow the research to proceed at a faster rate.  The 
two strains are similar genetically so research on M. marinum is useful in understanding 
the pathogenesis of M. tuberculosis.  These two pathogens also have a similar pathology 




M. marinum causes similar pathology in zebrafish suggesting similar pathogenic 
mechanisms.   
The goal of this thesis project was to identify the role of RD1 genes in intracellular 
growth.  To achieve this goal RD1 M. marinum mutants were used.  The in vitro 
sensitivity of RD1 mutants to ROIs was examined followed by cell infection assays to 
determine the role of ROIs in limiting RD1 mutant growth within macrophages.  Western 
blots were then used to identify the role of RD1 in the secretion of catalase and 
superoxide dismutase.  Combined, the results of these experiments can be used to 
confirm my hypothesis that RD1 contributes to intracellular growth via the secretion of 

























Figure 1. The RD1 and extended RD1 region of M. tuberculosis and M. marinum.  Filled 
areas represent extRD1 genes with directions of transcription, and filling colors indicate 
sequence similarities: black, >90%; dark gray, 70–89%; light gray, 55–69%; and open, 
<54%. RD1indicates M. tuberculosis genes deleted in BCG. Mh denotes M. marinum 
genes corresponding to M. tuberculosis homologues1.  
1Gao, L.Y et al.  A mycobacterial virulence gene cluster extending RD1 is required for 




Chapter 2: Results 
RD1 mutants are more sensitive to exogenous ROIs 
In a preliminary study I showed that certain RD1 mutants exhibited growth inhibition 
when grown in 7H9 broth medium lacking catalase.  However, this growth inhibition was 
not obvious for the wild type strain.  This requirement for catalase to grow led us to 
speculate that the RD1 mutants would have increased susceptibility to exogenously added 
H2O2. To test this possibility, we examined the growth of wild type and RD1 mutants that 
were exposed to 1 mM H2O2, by measuring OD600 at 3, 4, and 5 days after the exposure. 
This growth was then compared to that in 7H9 medium lacking H2O2 to get the value of 
percent inhibition.  As seen in Figure 2, wild type showed an average growth inhibition 
of 35%, while the RD1 mutant that had a deletion of both the esat-6 and cfp-10 genes 
























Figure 2. Sensitivity of wild type and RD1 mutant to 1mM H2O2.  All strains were grown in 
7H9 medium containing catalase. Then the cultures were passaged into 7H9 medium lacking 
catalase, with addition of 1 mM H2O2.  At 3, 4, and 5 days post H2O2 exposure, growth was 
analyzed by measuring the OD at wavelength 600nm.   Results are representative of one 
experiment performed in duplicate.  Statistical significance was examined with the Student t 
test, and P values were recorded. P values for 3, 4, and 5 days post H2O2 exposure are .0491, 
.0347 and .0207 respectively. 




























RD1 mutants are resistant to ROIs generated from within the bacteria 
 
To determine whether the hypersensitivity of the RD1 mutant to H2O2 was due to its 
deficiency in neutralizing ROIs from within the bacterial cell or in the extracellular 
milieu, we exposed wild type and the RD1 mutant to paraquat.  Paraquat is a reagent that 
enters the bacterium and combines with dioxygen to produce superoxide; an ROI that 
does not escape from the bacterium yet can be converted to H2O2 and other forms of 
ROIs.  The paraquat assays were performed following the same procedures as those in 
the H2O2 sensitivity assays.  Bacterial growth was determined by measuring OD600 at 3, 4, 
and 5 days after exposure to 1 mM paraquat and the growth inhibition was analyzed 
similarly as in the H2O2 assay. As seen in Figure 3, wild type and the RD1 mutant were 
equally resistant to paraquat, indicating that there were no significant differences between 
the two strains in their capacity to neutralize intracellular ROIs.  The results suggest that 
wild type and the RD1 mutant may have similar levels of intracellular ROI neutralizing 
enzymes, which implies that the difference between the two in sensitivity to exogenous 
ROI might be due to their difference in the production of ROI neutralizing enzymes into 






















Figure 3.  Sensitivity of wild type and RD1 mutant to 1mM paraquat.  Wild type and 
RD1 mutants were initially grown in 7H9 medium containing catalase.  Cultures were 
then passaged into 7H9 medium without catalase containing 1 mM paraquat. At 3, 4, 
and 5 days post inoculum, growth was analyzed by measuring the OD at wavelength 
600nm. Results are representative of one experiment performed in duplicate.  
Statistical significance was examined with the Student t test, and P values were 
































RD1 mutants are deficient for intracellular growth in activated macrophages 
Activated macrophages are known to produce large amount of ROIs to limit microbial 
growth. To examine whether the role of RD1 genes in resistance to the exogenous ROI is 
biologically significant during Mycobacterium infection of host cells, I performed a series 
of macrophage infection studies.  In these studies, wild type or RD1 mutants were used to 
infect activated BMDM at an MOI of 1, and bacterial intracellular growth was 
determined at 0, 24 and 48 hours after infection. The RD1 mutants used in these cell 
infection studies were ∆esat-6 (deletion of esat-6) and ∆cfp-10+esat-6 (deletion of both 
cfp-10 and esat-6). Both RD1 mutants displayed approximately 3-4 fold growth 
inhibition at 48 hours post infection when compared to wild type (Figure 4). The 
intracellular growth defect has been previously shown for multiple RD1 mutants, 
including ∆esat-6, of both M. tuberculosis and M. marinum.  However, the cause of the 




























Figure 4. Quantification of the intracellular growth of wild type and RD1 mutants 
in activated BMDM.  Macrophages were activated with both LPS and gamma 
interferon and infected at an MOI of 1.  At 0, 24, and 48 hours post infection, the 
cells were lysed, and the bacteria were serially diluted and spotted on to 7H10 
plates for enumeration of bacterial CFU.  Bars indicate standard deviation.  Results 




















The intracellular growth defect of the RD1 mutants can be recovered by the 
removal of ROIs    
In order to determine whether ROIs were involved in inhibiting the intracellular growth 
of the RD1 mutants, BMDM were treated with ROI-neutralizing enzymes to remove 
ROIs and the bacterial intracellular growth was examined.  The first approach I took was 
to treat the activated BMDM with superoxide dismutase and catalase (50 U/ml for each) 
to remove the ROIs generated by the macrophages. Superoxide dismutase breaks down 
superoxide to hydrogen peroxide and catalase works by breaking down hydrogen 
peroxide to water and oxygen.  The intracellular growth of M. marinum in those cells was 
compared to that without the treatment of the enzymes.  As shown in Figure 5, both RD1 
mutants had significantly increased intracellular growth in BMDM treated with the ROI-
neutralizing enzymes compared to that without the enzyme treatment.  On the other hand, 
the growth recovery for the wild type bacteria in the enzyme-treated cells was not 
evident.  These results suggest that the production of ROIs by the activated macrophages 
contributed to the inhibition of the intracellular growth of the RD1 mutants.  It was noted 
that although the RD1 mutants showed significantly recovered growth in the enzyme-
treated cells, their growth still did not reach to the level of the wild type strain, suggesting 
that other factor(s) besides ROIs might have been involved in inhibiting the growth of the 
RD1 mutants within the activated macrophages.  
The second approach I took was to treat the activated BMDM with 5 mM N-acetyl 
cysteine (NAC) to remove the ROIs produced by the cells.  Unlike superoxide dismutase 
or catalase which remove a specific species of ROI, NAC is able to remove multiple 




making it a more potent neutralizer of ROIs than the addition of the above two enzymes.  
As shown in Figure 6, the RD1 mutants showed an even higher growth recovery in the 
cells treated with NAC than in the cells treated with the two enzymes.  Interestingly, even 
wild type bacteria exhibited slightly increased growth in NAC-treated cells.  Although 
the increased growth of wild type is not statistically significant, there is still the 
implication that high levels of ROIs produced by activated macrophages can limit the 
intracellular growth of both wild type and the RD1 mutants but with a much higher 






















Figure 5. Intracellular growth of wild type and RD1 mutants in activated BMDM treated or 
not treated with 50U/ml SOD and 50U/ml catalase.  BMDM were activated with gamma 
interferon and LPS and infected at an MOI of 1.   At 0, 24 and 48 hours post infection, the 
cells were lysed and the bacteria were serially diluted and spotted on to 7H10 plates for 
enumeration of bacterial CFU. Inset figure shows the recovery of the RD1 mutants when 
treated with SOD and catalase at the 48-hour time point.  Results are representative of one 
experiment performed in duplicate.  Error bars indicate standard deviation. Statistical 
significance for results of inset figure was examined with the Student t test, and P values 
were recorded.  P values for wild type and ∆cfp-10+esat-6 are .3341and .0358 respectively.  




























































































Figure 6. Intracellular growth of wild type and RD1 mutants in activated BMDM treated or not 
treated with 5mM NAC.  BMDM were activated with gamma interferon and LPS and infected at an 
MOI of 1.   At 0, 24 and 48 hours post infection, the cells were lysed, and the bacteria were serially 
diluted and spotted on to 7H10 plates for enumeration of bacterial CFU. Inset figure shows the 
recovery of the RD1 mutants when treated with NAC at the 48-hour time point. Results are 
representative of one experiment performed in duplicate.  Error bars indicate standard deviation. 
Statistical significance for results of inset figure was examined with the Student t test, and P values 





































































RD1 mutants show no recovery in BMDM deficient in NADPH oxidase 
The NADPH oxidase enzyme complex is involved in producing abundant ROIs in 
activated neutrophils or macrophages.  To investigate whether the ROIs produced by the 
NADPH oxidase complex played a role in inhibiting the intracellular growth of the RD1 
mutants, I compared the growth of the mutants in BMDM from the gp91phox or p47phox-
knockout mice to that from the wild type mice.  Both gp91 and p47 are essential subunits 
of the NADPH enzyme complex.  The intracellular growth assays were performed 
similarly as described above. The results showed unexpectedly that the RD1 mutants and 
wild type did not gain growth recovery (Figure 7).  These results suggest that the ROIs 
produced by NADPH oxidase do not play a major role in limiting the intracellular growth 


































Figure 7. Intracellular growth of wild type and RD1 mutants in activated BMDM 
from gp91phox-/- and p47phox-/- mice. BMDM were activated with gamma 
interferon and LPS and infected at an MOI of 1.   At 0, 24 and 48 hours post 
infection, the cells were lysed, and the bacteria were serially diluted and spotted 
on to 7H10 plates for enumeration of bacterial CFU. Results are representative of 
































RD1 mutants show no growth recovery in BMDM deficient for iNOS 
Nitric oxide produced by the iNOS enzyme can react with superoxide to form an even 
more toxic radical, peroxynitrite, which is a potent antimicrobial agent.  I showed above 
that the removal of the ROIs produced by the NADPH oxidase complex did not benefit 
the growth of the RD1 mutants.  One possible explanation is that the superoxide 
produced by an NADPH oxidase-independent source reacted with nitric oxide generated 
by iNOS to form peroxynitrite, which might have produced a potent growth inhibition for 
the mutants.  To test this possibility, I examined the growth of the RD1 mutants in 
BMDM from iNOS-knockout mice and compared it to that from the wild type mice.  
Activation and infection of BMDM were performed similarly as described above.  The 
results showed that wild type or the RD1 mutants did not gain grow recovery in the 
iNOS-knockout macrophages (Figure 8).  In fact, both bacteria somehow showed slightly 
reduced growth in the knockout cells.  Therefore, the reactive nitrogen intermediates did 
not seem to play a role in inhibiting the intracellular growth of the RD1 mutants in 


























Figure 8.  Intracellular growth of RD1 mutant in BMDM from iNOS-/- mice.  BMDM were 
activated with gamma interferon and LPS and infected at an MOI of 1.   At 0, 24 and 48 
hours post infection, the cells were lysed, and the bacteria were serially diluted and 
spotted on to 7H10 plates for enumeration of bacterial CFU.  Results are representative of 
two experiments performed in duplicate. Error bars indicate standard deviation. Statistical 
significance was examined with the Student t test, and P values were recorded.  P values 




















RD1 genes may play a role in the synthesis and/or secretion of KatG 
 
To determine whether the increased sensitivity of the RD1 mutants to ROI was due to 
their defect in the synthesis and/or secretion of KatG, I examined the production of KatG 
in both the bacterial cell lysates and culture filtrates by Western blot analysis.  In my 
initial analysis, I analyzed KatG production by the bacteria grown in the Sauton’s 
minimum defined medium. No KatG was detected in the culture filtrates of both wild 
type and RD1 mutants, suggesting that the amount of KatG secreted into the Sauton’s 
medium was under the detectable level (data not shown).  Since a difference in the 
intracellular level of KatG may also explain differential sensitivity of wild type and RD1 
mutants to ROIs, the cell lysates of wild type and RD1 mutants were probed for KatG.  
The results presented in Figure 9A showed that the RD1 mutants had varying levels of 
KatG within the crude cell lysates.  Quantification of the KatG levels within the crude 
cell lysates showed that the differences between wild type (set at 100%) and the majority 
of the RD1 mutants might not be significant, except that the Mh3878::kan mutant 
produced strikingly more KatG than wild type (Figure 10).    
Previous research has suggested that KatG may be a cell wall associated protein, hence 
possible differences between wild type and the RD1 mutants in the amount of KatG 
associated with the cell wall might also explain the differences between them in the 
sensitivity to ROIs.  To analyze the differences in the cell wall-associated KatG, the 
cytosol plus cytoplasmic membrane fraction was separated from the cell wall fraction by 
centrifugation, and the cytosol plus cytoplasmic membrane fraction was probed for KatG 




mutants had varying levels of KatG in the cytosol plus cytoplasmic membrane fraction, 
for example the Mh3876::kan and Mh3879::kan mutants had much reduced levels of 
KatG compared to wild type.  Many other RD1 mutants showed more or less similar 
levels of KatG compared to wild type.  The Mh3878::kan mutant again showed much 
higher level of KatG than wild type.  However, wild type bacteria clearly did not show 
significantly reduced level of KatG when compared to most of the RD1 mutants, 
implicating that there was no differential localization of KatG on the wild type bacterial 
cell wall.  
The speculation that wild type bacteria grown in the 7H9 rich medium, rather than 
Sauton’s medium, might contain higher level of KatG than the RD1 mutants is intriguing, 
because all of the above described in vitro and cell infection experiments examining the 
sensitivity of RD1 mutants to ROIs were performed using the bacteria grown in 7H9 
medium.  Therefore, I wondered whether the different growth conditions might have 
caused the differences in the KatG levels in wild type or the RD1 mutant bacteria.  To 
further evaluate this possibility, I examined the KatG level in the cell lysates of wild type 
and RD1 mutants grown in 7H9 medium.  The results presented in Figures 13 and 14 
showed that wild type bacteria produced significantly more KatG than the RD1 mutants 
when grown in the 7H9 medium.  Quantification of the KatG levels indicated that the 
KatG level of wild type bacteria was approximately 3- and 2-times higher than that of the 
∆esat-6 and the ∆cfp-10+esat-6 mutants, respectively.  Therefore, the results indicated 
that wild type bacteria grown in the 7H9 rich medium produced a significantly higher 
level of KatG than the RD1 mutants, suggesting that the RD1 genes are possibly involved 




Another important aspect to look into was the dynamics of the KatG level in response to 
the exposure to ROIs.  Interestingly, after exposure to 1 mM H2O2, the KatG level of wild 
type bacteria dropped significantly within 2 hours by 150% (Figure 14).  This rapid drop 
of the KatG protein level in wild type bacteria can be accounted for by two possibilities, 
one is the degradation and the other the secretion of the KatG protein.  Intriguingly, the 
drop of KatG for both RD1 mutants after exposure to 1 mM H2O2 was not as evident as 
for wild type, implying that the drop of KatG level in wild type bacteria probably was not 
due to degradation but rather the secretion of KatG.  The above experiment was 
performed only once. If the results can be reproduced, the data would suggest that the 
RD1 genes might be involved in both the production/synthesis and the secretion of KatG 
when grown in the rich medium, consistent with the observation that wild type bacteria 
















































13. ∆esat-6   






Figure 9. Analysis of KatG within the crude cell lysate of wild type and RD1 
mutants grown in Sauton’s minimum defined media by Western blot.  Cell 
lysates were processed and proteins separated on a 4-20% gradient SDS gel.  
Proteins were probed with anti-KatG (A) and  anti-GroEL (B)  antibodies.  Lanes 
are indicated on the side of the blot.  These results are representative of a single 


















Figure 10 Quantification of KatG levels present in the samples presented in 
Figure 9.  Quantification was performed using ImageJ software.  The KatG levels 
were normalized according to the levels of GroEL. Wild type levels of KatG are 































































































































13. ∆esat-6   




Figure 11. Analysis of KatG localized to cytosol and plasma membrane for 
bacteria grown in Sauton’s minimum defined media.  Crude cell lysates were 
centrifuged to remove cell wall extract. The remaining cytosolic and plasma 
membrane proteins were separated on a 4-20% gradient gel and KatG was probed 
with an anti-KatG antibody. Lanes are indicated on the side of the blot.  These 






































































































Figure 12. Quantification of KatG levels present in the samples presented in 
Figure 11.  Quantification was performed using ImageJ software.  The KatG 
levels were normalized according to the levels of GroEL. Wild type levels of 
KatG are set to 100% so RD1 mutant levels of KatG are expressed as a percent of 



























1   2    3  4   5   6    7   8    9
1. Wt – 0 H2O2 
2. Wt – 1 mM H2O2 
3. Wt – 20 mM H2O2 
4. ∆esat-6 – 0 H2O2 
5. ∆esat-6 – 1 mM H2O2 
6. ∆esat-6 – 20 mM H2O2 
7. ∆cfp-10+esat-6  – 0 H2O2 
8. ∆cfp-10+esat-6 – 1 mM H2O2 
9. ∆cfp-10+esat-6 – 0 H2O2 
 
Figure 13. Analysis of KatG expression in the cell lysates of RD1 mutants 
grown in 7H9 medium following exposure to H2O2.  Wild type and RD1 
mutants were initially grown in 7H9 medium then exposed to H2O2 for 2 
hours prior to processing of cell lysate.   Proteins the cell lysates were 
separated on a 4-20% gradient gel and probed with anti-KatG antibodies (A) 
and anti-GroEl (B). Lanes are indicated on the side of the blot. These results 


























Figure 14. Quantification of the KatG protein levels for the samples presented 
in Figure 13. Quantification was performed using ImageJ software.  The KatG 
levels were normalized according to the levels of GroEL. Wild type levels of 
KatG are set to 100% so RD1 mutant levels of KatG are expressed as a 

























RD1 may play a role in the regulation of AhpC 
 
Published data has demonstrated a clear link between the production of KatG and AhpC, 
in which there is an induction of AhpC as compensation for a decrease of KatG.  
Therefore I examined whether the RD1 mutants, which as described above may be 
deficient in the production/synthesize and secretion of KatG, would express an increase 
in AhpC after exposure to ROIs such as H2O2.  AhpC protein was detected by Western 
blot, using the same cell lysates described above from bacteria grown in 7H9 medium for 
KatG analysis.  The results shown in Figures 15 and 16 showed that wild type bacteria 
expressed relatively constant levels of AhpC following exposure to H2O2.  However, the 
RD1 mutants showed markedly increased levels of AhpC following the H2O2 exposure. 
After exposure to 1 mM H2O2 ∆esat-6 and ∆cfp-10+esat-6 appeared to induce AhpC by 
approximately 125% and 100% more, respectively.  The results are consistent with the 
previously described link between KatG and AhpC and further support my above 






























































1   2    3   4   5   6    7   8    9 1. Wt – 0 H2O2 2. Wt – 1 mM H2O2 
3. Wt – 20 mM H2O2 
4. ∆esat-6 – 0 H2O2 
5. ∆esat-6  – 1 mM H2O2 
6. ∆esat-6 – 20 mM H2O2 
7. ∆cfp-10+esat-6  – 0 H2O2 
8. ∆cfp-10+esat-6 – 1 mM H2O2 
9. ∆cfp-10+esat-6 – 0 H2O2 
 
Figure 15.  Analysis of AhpC expression in the cell lysates of RD1 mutants  
grown in 7H9 medium following exposure to H2O2.  Wild type and RD1 
mutants were initially grown in 7H9 medium then exposed to H2O2 for 2 
hours prior to processing of cell lysate.   Proteins the cell lysates were 
separated on a 4-20% gradient gel and probed with anti-KatG antibodies (A) 
and anti-GroEl (B). Lanes are indicated on the side. These results are 




































Figure 16. Quantification of the AhpC protein levels for the samples presented in 
Figure 15. Quantification was performed using ImageJ software.  The AhpC 
levels were normalized according to the levels of GroEL. Wild type levels of 
AhpC are set to 100% so RD1 mutant levels of AhpC are expressed as a 























The role of RD1 genes in the synthesis and/or secretion of superoxide dismutase is 
inconclusive  
 
Here I examined another ROI-scavenging enzyme, superoxide dismutase.  My 
preliminary study focused on the secretion of this enzyme by wild type and the RD1 
mutants.  I first examined the enzyme activity in the culture filtrates of wild type and the 
RD1 mutants grown in Sauton’s minimum defined medium.  The culture filtrate proteins 
were separated by a 15% non-denaturing agarose gel and the superoxide dismutase 
enzyme activity was detected by incubation with nitroblue tetrozolium.  As seen in 
Figures 17A and 18A, the RD1 mutants and wild type bacteria all showed the clear band 
for superoxide dismutase at varying degrees of intensity.  In general, the wild type 
bacteria produced little superoxide dismutase activity compared to the RD1 mutants.  
Some RD1 mutants, such as Mh3868a::kan, Mh3868b::kan, Mh3868c::kan, 
Mh3867::kan, and the ∆esat-6 mutants secreted much more SodA compared to wild type.  
The above results of the enzymatic activity were further confirmed by Western blot 
assays shown in Figures 17B and 18B.  It is also interesting to note that the SecA2 mutant 
appears to secrete superoxide dismutase despite previous studies that imply that SodA 
may be secreted via the SecA2 secretion system (Braunstein, 2003).  However, the 
secretion of SodA is not likely to be exclusive to SecA2 given the fact that when 
secretion is analyzed under different growth phases, the SecA2 mutant has been shown 
secrete SodA, which is confirmed in by our Western blot.    
Generally, the results demonstrate that RD1 mutants secrete equivalent or even higher 
levels of superoxide dismutase than wild type when the bacteria are grown in the 
Sauton’s medium.  As I described above, RD1 genes are likely involved in the synthesis 




conclusive whether these genes play a similar role in the synthesis and/or secretion of 








































































Figure 17. Analysis of the protein levels of superoxide dismutase in the culture filtrate 
of wild type and RD1 mutants grown in Sauton’s defined minimal media. A) SodA 
enzymatic activity. The nondenatured culture filtrate was separated by a 15% gel.  
Activity was measured by incubation with nitroblue tetrozolium followed by a solution 
of TEMED, riboflavin and potassium phosphate.  B) Western blot probing for SodA.  
Proteins of the culture filtrates were separated by a 4-20% gradient gel and SodA was 
probed with anti-SodA antibodies. C) Western blot probing for Antigen 85, which is 
protein secreted via the SecA1-dependant pathway.  Lanes are indicated on the side. 











































































































































































Figure 18. Quantification the enzymatic activity (A) and protein levels (B) of 
SodA for the samples presented in Figures 17 A and B. Quantification was 
performed using ImageJ software.  Wild type level of SodA was set to 100% so 




Chapter 3: Experimental procedures 
Bacterial Strains and Media 
RD1 mutant strains were created by Gao et al, 2003.  Bacteria were cultures in 
Middlebrook 7H9 (Difco) supplemented with 0.2% glycerol, 0.05% Tween 80, and 10% 
albumin-dextrose-catalase enrichment (7H9 broth) or on Middlebrook 7H10 agar (Difco), 
supplemented with 0.5% glycerol and 10% oleic acid-albumin-dextrose-catalase 
enrichment. Antibiotics used for RD1 mutant media was kanamycin (30 µg/ml) Initial 
inoculums were cultured at 32˚C with shaking (100RPM) to confluence.  Cultures were 
then concentrated in 7H9 containing 30% glycerol and stored at –80C for subsequent use.   
Cell Culture Lines 
Bone marrow derived macrophages were derived from bone marrow exudates of cells 
extracted from the femurs of female 6-week-old C57BL/6 mice obtained from Jackson 
laboratories (Bar Harbour, Maine).  Cells were flushed using 2% FBS in PBS.  Following 
isolation and washes, cells were cultured for four days at 37˚C in 5% CO2.  The media 
used for culturing BMDM was Dulbecco’s Modified Eagle Media (DMEM) modified 
with 10% fetal bovine serum, 15% L929 cell supernatant, 1% glutamine and 2% HEPES 
buffer.  After four days, fresh media was added to the cells and culture was maintained 
four more days before further processing. Bone marrow derived macrophages were also 







 Hydrogen Peroxide and Paraquat (methyl violegen) in vitro Assays 
Wild-type M. marinum and RD1 mutants ∆esat-6 and ∆cfp-10+esat-6 were grown in 
7H9 liquid medium with catalase to late log phase (OD600≈1.2-1.5).  All bacterial cultures 
were standardized to OD600= 1.2 by diluting with 7H9 without catalase medium.  130ul 
of the standardized bacterial culture were further diluted with 1ml 7H9 without catalase 
medium.  125 µl of this solution was then inoculated into Erlenmeyer flasks containing 
30ml 7H9 without catalase.  Hydrogen peroxide and paraquat solutions with specific 
concentrations were also prepared with 7H9 without catalase culture medium and then 
inoculated into flasks with cultures.  Cultures were grown in 32˚C with constant shaking 
(100RPM).  Three days after the initial inoculum, OD600 readings were taken to measure 
bacterial survival after initial exposure to extracellular hydrogen peroxide and paraquat.  
The statistical analysis of the data were performed with Student’s t test using Graph 
Prism software. 
Bone Marrow Derived Macrophage Infection 
BMDM cells were seeded at a density 2.5 x 105 per ml or 5x104 per well in 96 
well plates.  Cells were activated one day prior to infection by treatment with BMDM 
infection medium containing interferon gamma at a concentration of 100 U/ml.  BMDM 
infection media consists of DMEM, 10% FBS, 1% glutamine and 2% Hepes buffer. Cells 
were conditioned at 32˚C for 24 hours prior to infection.  Two hours prior to infection, 
cells were treated with infection medium containing 10 ng/ml LPS. For recovery assays, 
ROI-inhibitors were also added at this time.  Cells were treated with either 50 U/ml 





Prior to infection bacteria were grown to OD600 of 1.2-1.5.  Bacteria were 
processed by washing with PBS followed by isolation of single bacteria by passage 
through a 26G needle two times.  Bacteria concentrations were adjusted in BMDM 
infection media with the required concentration of superoxide dismutase /catalase and 
NAC.  Bacteria were added to BMDMs to establish a multiplicity of infection of 1.  After 
a two-hour incubation at 32ºC at 5% CO2 pressure, cells were washed three times with 
PBS.   Cells were then incubated with infection media containing 4 µg/ml streptomycin 
as well as the appropriate concentration of the ROI inhibitor used for that infection. 
At each time point, 0 (immediately after two hour infection), 24 and 48, cells 
were lysed using cell lysis media triton.  For the time 0 and 24-hour time points, cells 
were lysed by the addition of 200 µl of 0.1% triton followed by a ten-minute incubation 
at 32˚C.  After resuspending, 20 µl was transferred to 180 µl of PBS.  Six 1:10 serial 
dilutions were made and 10 µl of each dilution was spotted onto a 7H10 plate.  For the 
48-hour time point, the 200 µl supernatant was combined with 20 µl of 4% triton.  The 
adherent cells were treated with 200 µl of 0.1% triton.  After a 10-minute incubation both 
supernatant and adherent cells were resuspended and 20 µl from each was transferred to 
160 µl PBS for serial dilutions.  
For each infection, untreated wild type BMDM were infected simultaneously with the 
BMDM treated with ROI inhibitors.  Cell infections with untreated BMDM followed the 
same procedures with the exception being the addition of the ROI neutralizing reagents.  
Infections performed on mutant cell lines (iNOS-/-, gp91phox-/-, and p47phox-/-) followed the 
same procedure as those used to infect wild type untreated BMDM.  The statistical 




Culture filtrate and cell lysate preparation of RD1 mutants 
RD1 mutants were inoculated from frozen stock into 7H9 medium. This culture 
was passed two times into Sauton’s minimal media. Each passage was done at the point 
that the cultures had reached confluence as determined by OD600 of 1.2 to 1.4.The final 
cultures were grown for 6 days.  The culture filtrate was separated via centrifugation at 
3800 RPM for ten minutes followed by filtration through a filter cup.  The remaining 
pellet containing whole cells was frozen at –80˚C.  EDTA (pH 7-8) was added to the 
culture filtrate at a concentration of 1 mM.  The culture filtrate was then concentrated to 
1ml by ultracentrifugation at 4˚C using centriplus ultracentrifugation tubes. Cocktail 
proteinase inhibitor was added to concentrated culture filtrate. Culture filtrates were 
normalized to the weight of the pellets and adjusted to 1011 bacteria/ml. 
Prior to preparation of whole cell lysates, pellets were measured and concentrations were 
normalized by resuspending in 20 mM Tris buffer (pH=7.5), containing a cocktail of 
proteinase inhibitors. Cells were then subjected to four rounds of bead beating performed 
at maximum speed for thirty seconds per round.  Between each round cells were kept on 
ice.   Tubes were then centrifuged two times at 3000xg at 4˚C for 10 minutes.  The 
remaining supernatant was crude cell lysate containing cell wall, cytosol, and plasma 
membrane. 
To remove the cell wall portion, the crude cell lysate was centrifuged at 16,000xg for 60 
minutes. The pellet was washed two times and saved as the cell wall fraction. Prior to 
use, culture filtrates and cell lysates were normalized using the BCATM Protein Assay Kit 




For induction experiments bacteria were grown from frozen stock in 7H9 liquid medium 
with catalase to late log phase (OD600≈1.2-1.5). Cultures were adjusted to OD600  1.0 prior 
to treatment with 1 mM or 20 mM H2O2 .  Cultures were incubated with H2O2 for two 
hours prior to processing of cell lysates. Processing of cell lysates occurred as previously 
described. 
Immunoblot analysis of culture filtrate proteins and whole cell lysates 
Culture filtrate proteins and whole cell lysates were subject to SDS-PAGE.  20 µl of 
normalized protein was loaded onto 4-20% gradient gel for each strain. This was 
followed by transfer to nitrocellulose membrane followed by visualization by 
chemiluminescence (BioRad) Antibodies used to probe membrane include rabbit 
polyclonal anti-M. marinum KatG (titer 1:2500), Rabbit polyclonal anti-Mtb SodA 
antibody (titer 1:2000), rabbit polyclonal antigen 85  antibody (titer 1:2000), rabbit 
polyclonal AhpC antibody (titer 1:500) and mouse monoclonal GroEL antibody (titer 
1:50).   
The SodA and Antigen 85 antibodies were obtained from Marcus Horwitz’s lab at 
UCLA. The KatG antibody was obtained from NIH. The GroEL antibody was obtained 
from Colorado State University.  The AhpC antibody was obtained from Dr. Steward 
Cole at the Institut of Pasteur. 
Superoxide dismutase Activity Assay 
For superoxide dismutase enzymatic assay culture filtrate was run through a non-
denaturing agarose gel made up of a 15% stacking gel and a 15% separating gel at 4˚C.  




deficient in SDS prior to loading.  Once the gel was run, it was incubated for 30 minutes 
in a solution of 2.5 mM nitro blue tetrazolium.  This was followed by a 20-minute 
incubation with a solution made up of 30 mM potassium phosphate, 30 mM TEMED and 






Chapter 4: Discussion 
Although RD1 is well documented to play a critical role in mycobacterium growth within 
host macrophages (Stanley, 2003), it is not understood what host defense mechanism 
RD1 counteracts.  It is also not clearly known how the proteins are secreted by RD1 and 
what functions the secreted proteins have.  I hypothesize that the virulence function of 
RD1 is achieved by secreting neutralizing enzymes, such as catalase and/or superoxide 
dismutase, that counteract the reactive oxygen and nitrogen intermediates produced by 
the host cell.  This hypothesis was supported in part by my initial observation that the 
RD1 mutants grew slower than wild type in 7H9 medium with no supplemental catalase. 
The hypothesis was further supported by the observation that the RD1 mutants had 
significantly reduced growth compared to wild type in 7H9 medium containing 1 mM 
H2O2.  These results suggested that somehow the RD1 mutants were unable to effectively 
neutralize H2O2.  However, this does not exclude other possibilities.  For example, one 
possibility is that the mutants might be less able to repair the oxidative damage by H2O2, 
another possibility is that the mutants’ cell wall might be more permeable to H2O2.  These 
possibilities are discussed in more detail below and elsewhere in this chapter.  
In order to determine whether the mutants’ defect in neutralizing ROI is due to lack of 
secretion of neutralizing enzymes or their synthesis within the bacterial cell, we 
examined the sensitivity of wild type and RD1 mutants to paraquat, a chemical that 
generates superoxide within the bacterial cell, which then is converted to other forms of 
ROIs in the bacteria.  The results showed that wild type and RD1 mutants had 
comparable growth in the presence of paraquat, suggesting that RD1 may play a role 




permeability to H2O2.  These results argue against the possibility that RD1 is involved in 
repairing damage caused by ROIs.  Together, the above in vitro assays support my initial 
hypothesis that RD1 may be involved in the secretion of catalase and/or superoxide 
dismutase that participate in the neutralization of ROIs.   
To further support my hypothesis, I performed macrophage cell infection studies, in 
which I demonstrated that RD1 played an important role in counteracting ROIs produced 
by the host cell.  Consistent with published results, I showed that RD1 mutants had a 
marked defect in intracellular growth within activated BMDM as compared to wild type.  
Importantly, I showed that upon removal of ROIs produced by activated macrophages, 
using the exogenously added superoxide dismutase and catalase or NAC, RD1 mutants 
exhibited a significant recovery of growth, to a greater extent than wild type.  The results 
indicate that the negative pressure that limits the intracellular growth of the RD1 mutants 
in part comes from ROIs suggesting that the mutants are ineffective in neutralizing ROIs 
produced by the host cell.  The fact that the wild type did not recover to the same extent 
as the mutants suggests that the ROIs within the macrophages were not affecting the wild 
type as much as the mutants.  Therefore, I conclude that RD1 genes play an important 
role in the neutralization of ROIs within activated macrophages. 
In order to determine the source of ROIs that was involved in limiting the growth of RD1 
mutants, I examined the intracellular growth of wild type and RD1 mutants in p47phox-/- or 
gp91phox-/- BMDM.  Interestingly, the mutants did not show any growth recovery in both 
knockout macrophages, implicating that an NADPH oxidase-independent source of ROIs 
was enough to limit the mutant’s intracellular growth.  There are three possibilities that 




independent pathway produces the predominant source of ROIs that directly affect the 
intracellular growth of RD1 mutants within activated BMDMs.  The second possibility is 
that the NADPH oxidase-independent source of ROIs limits the mutants’ growth by an 
indirect mechanism.  The third possibility is that the NADPH oxidase-independent source 
of ROIs is sufficient to react with nitric oxide to produce the highly toxic compound, 
peroxynitrite, which limits the intracellular growth of the RD1 mutants.   Below are the 
in-depth discussions on those possibilities.  
With respect to the possibility that an NADPH oxidase-independent pathway produces 
the predominant source of ROIs that directly limits intracellular growth of RD1 mutants, 
it has been reported that oxidases other than NADPH oxidase play a significant role in 
inhibiting the intracellular growth of certain pathogenic bacteria.  For example, xanthine 
oxidase has been reported to play a role in inhibiting the dissemination of Salmonella, 
possibly by inhibiting the intracellular growth of the bacterium (Umezawa, 1997). 
Although NADPH oxidase has been considered the primary source of ROIs for 
phagocytes, it is not known whether it definitely plays a primary role in limiting the 
intracellular growth of RD1 mutants in our experiments due to the following two possible 
reasons.  One reason is that it is not clearly understood whether NADPH oxidase 
generates the primary source of ROIs in BMDM during the cell activation by IFN-γ.  
Measuring and comparing the amount of ROIs produced by BMDMs derived from wild 
type and the phox-knockout mice should provide some insight into this possibility.  It 
would also be beneficial to include the katG∆ as a positive control in phox-/- infection 
experiments since published data demonstrates that the katG∆ shows increased growth in 




ROI levels in the activated BMDM before and after the treatments with superoxide 
dismutase and catalase or NAC to in order to determine whether the ROI levels in treated 
BMDM are similar to those within the phox-/-  BMDMs.   
The other reason is that it is not known whether NADPH oxidase localizes to the 
mycobacterium-containing phagosome.  Salmonella has been shown to inhibit the 
recruitment of the NADPH oxidase subunits to the Salmonella-containing vacuole 
(Vazquez-torres, 2000).  Although inhibition of the recruitment of NADPH oxidase to the 
mycobacterium-containing vacuole has not been experimentally tested, it has been shown 
that mycobacterium inhibit the recruitment of iNOS to the bacteria containing phagosome 
(Miller, 2004).  Examining the recruitment of NADPH oxidase to mycobacterium-
containing phagosome should provide insight into this possibility.   
With respect to the possibility that the NADPH oxidase-independent source of ROIs may 
limit the mutant’s growth by an indirect mechanism, it is noteworthy that the cytosolic 
ROIs derived from mitochondria may play a role.  In order to determine whether 
mitochondria-derived ROIs play a role in inhibiting the RD1 mutants’ growth, specific 
inhibitors to these ROIs could be utilized.  If the mitochondria-derived ROIs are the main 
source of ROIs to inhibit bacterial growth then the inhibition of these ROIs should allow 
the RD1 mutants to recover to a level similar to that seen by the inhibition of ROIs by the 
addition of NAC.   
Mitochondria-derived ROIs are increased upon exposure to LPS and this increase is 
believed to trigger many signaling pathways including NFκB.  Published data suggest 
that the addition of NAC to activated macrophages can block NFκB activation (Sim, 




transcription factor (Liang, 2004).  Thus it is possible that the addition of NAC or 
superoxide dismutase/catalase to BMDM would inhibit ROIs that are involved in the 
signaling pathways, and this inhibition would allow the RD1 mutants to recover their 
deficient intracellular growth in activated macrophages.  This would suggest that the role 
of RD1 in neutralizing ROIs might be more important for the neutralization of 
mitochondria-derived ROIs for the purpose of inhibiting cell signaling, which possibly 
leads to reducing apoptosis.  However our in vitro studies suggest that the role of RD1 in 
neutralizing ROIs is more important in directly inhibiting the effects of the exogenous 
ROIs.  Therefore, it is equally possible that the mitochondria-derived ROIs may be 
involved in direct inhibition of the intracellular growth of RD1 mutants. Thus, RD1 may 
play either or both roles, one is to directly protect the bacteria by reducing the levels of 
ROIs in the bacteria-containing vacuole, and the other is to indirectly protect the bacteria 
by reducing the overall ROI level within the cell leading to dampening of the ROI-
mediated signaling.  If the inhibition of cell signaling were more crucial, it would be 
anticipated that the removal of only the proximal ROIs from the bacteria-containing 
vacuole via inactivation of the NADPH oxidase might not provide a significant benefit to 
the RD1 mutant bacteria.  An important experiment to test this possibility would be to 
selectively inhibit the mitochondria-derived ROIs and then observe the ability of RD1 
mutants to grow within these cells.  Since mitochondria-derived ROIs have been linked to 
cell signaling, then the recovery of RD1 mutants after the removal of these ROIs would 
indicate that RD1 mutants are more susceptible to the effect of the ROI-mediated 
signaling pathways rather than the direct effect of the ROIs on the bacteria.  The next step 




mitochondria-derived ROI inhibitors.  In order to demonstrate that the inhibition of the 
ROI-mediated signaling might have accounted for the growth recovery of the RD1 
mutants, it would then be necessary to further examine the growth of RD1 mutants in the 
cells upon treatment with an inhibitor for a particular cell signaling pathway, such as an 
inhibitor for the NFκB signaling pathway. 
To examine the possibility that the NADPH oxidase-independent source of ROIs may 
react with nitric oxide to produce peroxynitrite, wild type and RD1 mutants were used to 
infect iNOS-/- cells and the results showed no apparent recovery for the RD1 mutants.  
Therefore, RNI apparently is not involved in limiting the intracellular growth of RD1 
mutants in activated macrophages.  Interestingly, wild type bacteria also showed no 
recovery.  This result is unusual since published data suggest that the removal of RNI 
provides a significant benefit to wild type M. tuberculosis (MacMicking, 1997).  It is 
possible that M. marinum are less sensitive to RNI as compared to M. tuberculosis 
although further experimentation is necessary to figure this out. 
Based on the results of the above experiments and the discussions, it is reasonable to 
conclude that RD1 genes contribute to the bacteria’s ability to survive the toxic effects of 
the reactive oxygen intermediates both in vitro and in activated macrophages.  However, 
the precise mechanism by which RD1 works in this process is not clear.  I hypothesize 
that the RD1 secretion system is required to secrete the enzymes superoxide dismutase 
and/or catalase, which neutralize ROIs.  My initial attempts to testing this hypothesis 
were unsuccessful.  In those initial studies, I examined by Western blots the SodA and 
KatG protein levels in culture filtrates or whole cell extracts from wild type and RD1 




mutants were not significantly different from wild type in the synthesis of KatG and the 
secretion levels of the enzyme were too low to be detected, although the secretion of 
SodA was more prominent for the mutants than wild type.  The results of this analysis 
were rather contradicting to the observed phenotypes of the mutants both in vitro and in 
cell infections studies.  However, as will be discussed below, when the bacteria were 
grown in the 7H9 rich medium, the opposite phenotypes were observed compared to the 
Sauton’s minimum defined medium.  At this moment, we do not know how the different 
growth conditions caused the significantly different phenotypes. This will be a direction 
of future studies.       
There is a potential problem with using the bacteria grown in the Sauton’s minimum 
defined medium to measure enzyme secretion and synthesis.  It is important to note that 
in all our in vitro and cell infection experiments; the bacteria were grown in 7H9 but not 
Sauton’s medium, indicating that experimentation on the 7H9-grown bacteria would be 
more relevant to the observed phenotypes.  In support of this notion, I demonstrated that 
wild type bacteria grown in 7H9 did produce much higher levels of KatG in the bacterial 
cell than the RD1 mutants grown under the same conditions.  This result is consistent 
with the observation that the RD1 mutants are more sensitive than wild type to ROIs in 
vitro and within activated macrophages.  These results suggest that RD1 genes may be 
involved in the production/synthesis of KatG.  However, our paraquat experiment 
suggested the opposite, that RD1 genes likely are not involved in the intracellular levels 
of the ROI-neutralizing enzymes.  A possible mechanism that can explain the opposite 
observations would be that the RD1 genes are involved in the secretion of KatG, which 




support to this possibility, I examined the KatG levels in the bacterial cell after exposure 
to H2O2.  I observed that after 2 hours of exposure to H2O2, wild type bacteria showed a 
significant reduction of its KatG level in the cell lysates by approximately 150%.  On the 
other hand, this reduction of KatG level was not significant for the RD1 mutants.  These 
results suggest that RD1 genes may be involved in the secretion of KatG after the 
exposure of wild type bacteria to exogenous ROI such as H2O2, consistent with all our 
observations in the in vitro and cell infection studies.  A further study is imperative to 
examine the KatG levels in the culture medium of wild type and RD1 mutants after the 
induction with H2O2.  Exposing the bacteria to H2O2 for longer time points and 
measurement of KatG expression levels at various growth stages may provide further 
insight into the differences between wild type and RD1 mutants in terms of KatG 
synthesis and secretion.  Another useful experiment to establish the function of KatG 
secretion in contributing to intracellular growth would be to create an RD1 mutant 
capable of secreting KatG through an RD1 independent mechanism.  This mutant should 
show increased survival in activated BMDM, confirming the role of KatG secretion in 
counteracting host defense mechanisms.  The results of these studies should further 
establish an important unknown link between RD1 and KatG. 
One possible explanation for the link between RD1 and KatG could be explained by the 
involvement of RD1 in a unique oxidative stress response.  In M. bovis BCG, ahpC 
expression increases upon exposure to hydrogen peroxide.  However in the pathogenic 
strains M. bovis and M. tuberculosis, expression of ahpC is constitutively lower and no 
induction occurs (Springer, 2001).  Since BCG lacks RD1 it is possible that RD1 is 




lysates of the RD1 mutants grown in 7H9 and exposed to H2O2 were probed for AhpC.  
The results showed that RD1 mutants, but not wild type, exhibited significant 
upregulation of AhpC 2 hours after exposure to H2O2.  AhpC induction is somewhat 
linked to avirulence, the mechanism of this AhpC-mediated attenuation is not understood.  
It has been shown that AhpC induction compensates for the lack of KatG in the bacterial 
cell (Sherman, 1996).  Therefore, it is possible that the induction of AhpC in the RD1 
mutants represented a deficiency of KatG, explaining indirectly why the RD1 mutants 
were more sensitive to the exogenous ROIs.  This difference between wild type and RD1 
mutants in the induction of AhpC remains an area that demands increased attention and 
future experimentation. 
The results of the Western blot analysis of wild type and RD1 mutant KatG expression 
under 7H9 conditions indirectly support the hypothesis that RD1 may be involved in the 
secretion of KatG.  While the results of SodA secretion are inconclusive, it remains a 
possibility that analysis of secretion under more relevant growth conditions; RD1 may be 
implicated in the secretion of this enzyme as well.  However, previous studies suggest 
that both KatG and Sod A secretion is SecA2 dependant (Braunstein, 2003).  The basis of 
this claim comes from analysis of SodA and KatG secretion by a SecA2 mutant.  
However, this mutant only shows a defect in SodA secretion when the culture filtrate is 
analyzed after 3 days and again at 7 and 14 days.  However, when secretion is measured 
at 5 days, the mutant appears to secrete SodA.  Similarly, the SecA2 mutant appears to be 
defective in secretion of KatG only at 3 days, when the culture filtrate is collected and 
probed for KatG at later time points, there is not a significant difference between mutant 




are able to secrete the enzymes SodA and KatG depending on their growth phase.  Thus it 
is likely that SodA and KatG secretion are not mediated exclusively by SecA2.  
Therefore, it remains possible that RD1 may also play a role in the secretion of these 
enzymes, possibly by working in concert with the SecA2 secretion system.  Further 
research will be necessary to establish this possible link. 
Overall the results of this project are extremely promising in predicting the role of RD1 
genes in virulence.  The in vitro assays suggest a direct role for RD1 in neutralizing 
ROIs.  The cell infection assays confirm this role, indicating that the neutralization of 
mitochondria-derived ROIs may be more important for bacteria than the neutralization of 
ROIs generated by NADPH oxidase.  From what is known regarding the importance of 
mitochondrial ROIs in macrophage activation, it is not surprising that mycobacterium 
would seek to eliminate these chemicals.  The mechanism by which RD1 eliminates ROIs 
may be through the production of KatG to the cell wall and extracellular milieu, 
particularly following the exposure to H2O2.  This would suggest a novel role for the 
secretion system, possibly contributing to regulation as well as export of important ROI 
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